Vaxart director granted stock and options
Vaxart, Inc. director James B. Breitmeyer reported equity awards dated July 16, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vaxart, Inc. director James B. Breitmeyer reported equity awards dated July 16, 2026. He acquired 8,315 shares of common stock in connection with restricted stock units that will vest on the earlier of the date immediately prior to the 2027 annual stockholder meeting and July 16, 2027, bringing his direct holdings to 87,115 shares. He was also granted options on 16,610 shares at an exercise price of $0.5149 per share, expiring July 16, 2036, with the options subject to the same vesting schedule.
Insider Trade Summary
Grant/Award: 24,925 shares
Grant/Award
2 txns
Insider
BREITMEYER JAMES B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) F2 | 16,610 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 8,315 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (right to buy) — 16,610 contracts (Direct);
Common Stock — 87,115 shares (Direct)
Footnotes (2)
- F1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.
- F2. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
Key Figures
Common stock award: 8,315 shares
Common shares held after grant: 87,115 shares
Option grant size: 16,610 options
+3 more
6 metrics
Common stock award
8,315 shares
Shares acquired in connection with restricted stock units on July 16, 2026
Common shares held after grant
87,115 shares
Direct Vaxart common stock holdings after the stock award
Option grant size
16,610 options
Stock options (right to buy) granted on July 16, 2026
Option exercise price
$0.5149 per share
Conversion or exercise price for the 16,610 stock options
Option expiration
July 16, 2036
Expiration date of the reported stock options
Vesting latest date
July 16, 2027
Latest vesting date for both stock and option awards
Key Terms
restricted stock units, stock options (right to buy), exercise price, vesting
4 terms
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options (right to buy) financial
"Stock Options (right to buy) with an exercise price of 0.5149."
exercise price financial
"conversion_or_exercise_price: "0.5149" per share for the options."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares underlying the award shall vest on the earlier of the date immediately prior to the 2027 annual meeting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Vaxart (VXRT) director James B. Breitmeyer receive?
James B. Breitmeyer received 8,315 shares of common stock and 16,610 stock options. The stock grant is linked to restricted stock units, and the options are exercisable for common shares at a specified exercise price and term.
What is the exercise price and term of the new Vaxart (VXRT) stock options?
The options give the right to buy 16,610 shares of Vaxart common stock at an exercise price of $0.5149 per share. These options expire on July 16, 2036, providing a long-dated incentive grant to the director.
What is the vesting schedule for James B. Breitmeyer’s Vaxart (VXRT) restricted stock and options?
Both the 8,315-share stock award and the 16,610-share option grant vest on the earlier of the date immediately prior to Vaxart’s 2027 annual stockholder meeting and July 16, 2027, effectively tying vesting to either time or that meeting.
Are James B. Breitmeyer’s new Vaxart (VXRT) holdings reported as direct or indirect ownership?
The filing reports both the 8,315 shares of common stock and the 16,610 stock options as direct holdings. No indirect ownership entities or special ownership arrangements are referenced for these specific awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates